Olive View DoM

Jimenez PA, Sofen HL, Bissonnette R, Lee M, Fowler J, Zammit DJ, Chen Y, Rao N, Denis L, Gupta S. Oral SYK/JAK Inhibitor Gusacitinib for[...]

Since 1885, the Association of American Physicians (AAP), an honorary medical society, has advocated for the advancement of scientific and practical medicine by promoting professional and[...]

Batiuk E, Bassett M, Hakar M, Lin HC, Hunter AK. A rare case of primary gastric Hodgkin lymphoma in an adolescent with Nijmegen breakage syndrome.[...]

Schaffer AJ, El-Harasis MA, Tinianow A, Azose A, Zalawadiya S, Dee K, Balsara K, Montgomery JA. Clinical Outcomes in Patients With Bacteremia and Concomitant Left[...]

Forman LM, Sapisochin G, Assis DN, Arrivé L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian JH. Reply:[...]

Hanna C, Pettersen K, Pedley N. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med. 2023[...]

Koretz RL. JPEN Journal Club 77. Adjusting for confounders. JPEN J Parenter Enteral Nutr. 2023 Apr 8. doi: 10.1002/jpen.2505. Epub ahead of print. PMID: 37031359.

Malik A, Amjad W, Inayat F, Nadeem M, Weissman S, Malik MI, Jajja AA, Khan A, Tabibian JH. The effects of liraglutide on liver enzymes[...]

Law J, Trieu H, Kaleka G, Turkiewicz J, Palmer S, Lee JM, Chen KT, Tabibian JH. Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies[...]

LeVee A, Spector K, Larkin B, Dezem F, Plummer J, Dadmanesh F, Patil S, McArthur HL. Incidence and prognostic impact of HER2-positivity loss after dual[...]